Notice

Obesity Healthcare Goals

Updated 5 June 2025

© Crown copyright 2025

This publication is licensed under the terms of the Open 바카라 사이트 Licence v3.0 except where otherwise stated. To view this licence, visit or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at /government/publications/life-sciences-healthcare-goals/obesity-healthcare-goals

What we do

Obesity is one of the most pressing challenges facing our health system - approximately 1 in 3 people in the UK currently live with obesity. As a leading cause of multiple long-term conditions, including cardiovascular disease and cancer, obesity is estimated to cost the NHS over £11.4 billion every year, with wider societal costs estimated at £74.3 billion annually due to ill health.

In November 2022, the 바카라 사이트 launched the Obesity Healthcare Goals programme. The programme will explore how new and potentially transformative treatments and technologies can be developed and deployed to support people living with obesity. Its aim is to improve long-term health outcomes for people living with obesity and its associated conditions, while ensuring that the UK remains a world-class location to trial, pilot, and roll out innovations.

As a first step, in 2023, we , through the National Institute for Health and Care Research, to develop a Phase 2 pre-licence platform to evaluate pharmaceutical and digital interventions for obesity.

More recently, in October 2024, the 바카라 사이트 signed a landmark agreement with Eli Lilly, the world바카라 사이트™s largest pharmaceutical company, that will see the company invest £279 million in the UK. The collaboration will be a key initiative of the Obesity Healthcare Goals programme and aims to set the stage for government to work with industry to trial innovative approaches to treating obesity as part of a rounded package of care.

We are also funding a through Innovate UK. Through this, Innovate UK will invest up to £3 million to support NHS organisations to speed up the development of novel primary care and community-based patient access models that are safe, effective and resource efficient.

This work will mobilise systems for system pathway design to understand how it would be possible to accelerate patient access to Life Sciences innovations for the treatment of obesity - in line with shared Department for Science, Innovation and Technology (DSIT) and the Department of Health and Social Care (DHSC) priorities.

Who we are

The Obesity Healthcare Goals programme is Chaired by Professor Naveed Sattar.

I am delighted to chair the Obesity Healthcare Goals as obesity is perhaps the major cause of multiple long-term conditions in the UK.  I want to help promote the UK as an excellent place to do obesity research with its connectivity, high quality health records and academic talent. There are few places better for companies than the UK to best determine the benefits of new weight loss methods 바카라 사이트“ be they technological or pharmaceutical 바카라 사이트“ for people and society.

Professor Naveed Sattar, October 2023.

Naveed Sattar, Chair of the Obesity Healthcare Goals.

Naveed Sattar is a medical researcher and Professor of Cardiometabolic Medicine at the School of Cardiovascular & Metabolic Health at the University of Glasgow and is clinically active in cardiometabolic disease treatment and prevention as an Honorary Consultant at the Glasgow Royal Infirmary.

With over 25 years of academic experience and a remarkable track record of collaboration across a number of medical fields, Naveed is recognised as a world leading expert on obesity, diabetes and cardiovascular disease. Naveed enjoys challenging conventional wisdom, and his research on the pathogenesis, assessment and treatment of cardiometabolic conditions has helped shape clinical practice across the UK and Europe, leading to new insights in several areas.  He has also contributed to eight clinical guidelines for the treatment of cardiometabolic conditions, including obesity.

With over 1300 published papers authored Naveed has been in the top 1% of cited clinical academics in the world since 2014, receiving several national and international prizes for his research.  He has also extensively contributed to clinically significant trials in the field 바카라 사이트“ both lifestyle interventions and pharmaceutical trials 바카라 사이트“ as well as mechanistic insights behind the impact of weight loss in several conditions.

Contact details

You can contact the Obesity Healthcare Goals by email: healthcaregoals@officeforlifesciences.gov.uk

Back to top